Compare · EUCR vs INV
EUCR vs INV
Side-by-side comparison of Eucrates Biomedical Acquisition Corp. (EUCR) and Innventure Inc. (INV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EUCR and INV operate in Blank Checks (Finance), so they compete in similar markets.
- INV carries a market cap of $14.7M.
- INV has hit the wire 8 times in the past 4 weeks while EUCR has been quiet.
- INV has more recent analyst coverage (2 ratings vs 0 for EUCR).
EUCR
Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest EUCR
- SEC Form 15-12G filed by Eucrates Biomedical Acquisition Corp.
- SEC Form 25-NSE filed by Eucrates Biomedical Acquisition Corp.
- SEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.
- Reported Late Tuesday April 11, Eucrates Biomedical Acquisition Corp. Announces Liquidation; Co To Redeem All Outstanding Shares At A Per-Share Redemption Price Of ~$10
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Eucrates Biomedical Acquisition Corp. Announces Liquidation
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation
- SEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- SEC Form SC 13G/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)
Latest INV
- SEC Form 10-Q filed by Innventure Inc.
- Innventure Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Innventure Reports Third Quarter 2026 Results
- Innventure to Announce Third Quarter 2026 Results on November 12, 2026
- Accelsius Provides Two-Phase Direct-to-Chip Cooling to Support NSF ES2 Energy Efficiency Research at Villanova University
- Innventure Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Innventure Announces Formation of Strategic Review Committee to Review Range of Capital Strategies
- SEC Form 3 filed by Innventure Inc.
- SEC Form 8-K filed by Innventure Inc.
- INV UPCOMING DEADLINE: Levi & Korsinsky Alerts Innventure, Inc. Stockholders of Securities Class Action - Contact the Firm